Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Journal
Overview
publication venue for
Lung microbial and host genomic signatures as predictors of prognosis in early-stage adenocarcinoma.
2024
Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort.
2024
Associations of early-life and adult anthropometric measures with the expression of stem cell markers CD44, CD24, and ALDH1A1 in women with benign breast biopsies.
2024
Reproductive factors related to childbearing and a novel automated mammographic measure, V.
2024
Racial and ethnic disparities in the use of robot-assisted surgery and minimally invasive surgery in pelvic cancer treatment: a systematic review.
2023
Associations between etiologic or prognostic tumor tissue markers and neighborhood contextual factors in male health professionals diagnosed with prostate cancer.
2023
Underutilization of Guideline-Recommended Mismatch Repair/Microsatellite Instability Biomarker Testing in Advanced Colorectal Cancer. .
31.
2022
The Association between Smoking and Anal Human Papillomavirus in the HPV Infection in Men Study. .
31.
2022
Loss of PTEN Expression, PIK3CA Mutations, and Breast Cancer Survival in the Nurses' Health Studies.
2022
A multi-state survival model for time to breast cancer mortality among a cohort of initially disease-free women.
2022
Impact of Exercise on Susceptibility and Severity of COVID-19 in Patients with Cancer: A Retrospective Study. .
31.
2022
Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer.
2022
Plasma Metabolomics and Breast Cancer Risk Over 20 Years of Follow-up Among Postmenopausal Women in the Nurses' Health Study.
2022
Associations of oral contraceptives with mammographic breast density in premenopausal women.
2021
Regular Aspirin Use and Mortality in Multiple Myeloma Patients.
2021
A Metabolomics Analysis of Circulating Carotenoids and Breast Cancer Risk.
2021
Oral Cyanobacteria and hepatocellular carcinoma.
2021
Disease-Associated Risk Variants in ANRIL Are Associated with Tumor-Infiltrating Lymphocyte Presence in Primary Melanomas in the Population-Based GEM Study. .
30.
2021
Association of Prediagnostic Blood Metabolomics with Prostate Cancer Defined by ERG or PTEN Molecular Subtypes. .
30.
2021
Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium. .
30.
2021
Gene Expression Pathways in Prostate Tissue Associated with Vigorous Physical Activity in Prostate Cancer. .
30.
2021
Early-Life and Adult Adiposity, Adult Height, and Benign Breast Tissue Composition. .
30.
2020
Low Subcutaneous Adiposity and Mortality in Esophageal Cancer. .
30.
2020
Automated Quantitative Measures of Terminal Duct Lobular Unit Involution and Breast Cancer Risk. .
29.
2020
Association of Known Melanoma Risk Factors with Primary Melanoma of the Scalp and Neck. .
29.
2020
Risk of Breast Cancer Associated with Estrogen DNA Adduct Biomarker. .
29.
2020
Heterogeneity in Trust of Cancer Information among Hispanic Adults in the United States: An Analysis of the Health Information National Trends Survey. .
29.
2020
Premenopausal Plasma Osteoprotegerin and Breast Cancer Risk: A Case-Control Analysis Nested within the Nurses' Health Study II. .
29.
2020
Prediagnostic 25-Hydroxyvitamin D Concentrations in Relation to Tumor Molecular Alterations and Risk of Breast Cancer Recurrence. .
29.
2020
Mendelian Randomization of Circulating Polyunsaturated Fatty Acids and Colorectal Cancer Risk. .
29.
2020
Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response Relationships. .
29.
2020
The Association of Modifiable Breast Cancer Risk Factors and Somatic Genomic Alterations in Breast Tumors: The Cancer Genome Atlas Network. .
29.
2020
Early-Life and Adult Anthropometrics in Relation to Mammographic Image Intensity Variation in the Nurses' Health Studies. .
29.
2019
Identification of Novel Loci and New Risk Variant in Known Loci for Colorectal Cancer Risk in East Asians. .
29.
2019
A Prospective Study of Intraprostatic Inflammation, Focal Atrophy, and Progression to Lethal Prostate Cancer. .
28.
2019
Evidence for Etiologic Subtypes of Breast Cancer in the Carolina Breast Cancer Study. .
28.
2019
Urinary Metabolomics to Identify a Unique Biomarker Panel for Detecting Colorectal Cancer: A Multicenter Study. .
28.
2019
Targeted Cancer Next-Generation Sequencing as a Primary Screening Tool for Microsatellite Instability and Lynch Syndrome in Upper Gastrointestinal Tract Cancers. .
28.
2019
Comparison of Questionnaire-Based Breast Cancer Prediction Models in the Nurses' Health Study. .
28.
2019
Atypical Chemokine Receptor 1 (DARC/ACKR1 ) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African Ancestry. .
28.
2019
Cancer Health Impact Program (CHIP): Identifying Social and Demographic Associations of mHealth Access and Cancer Screening Behaviors Among Brooklyn, New York, Residents. .
28.
2019
Particulate Matter and Traffic-Related Exposures in Relation to Breast Cancer Survival. .
28.
2019
PAM50 Molecular Intrinsic Subtypes in the Nurses' Health Study Cohorts. .
28.
2018
Low Tristetraprolin Expression Is Associated with Lethal Prostate Cancer. .
28.
2018
A Prospective Study of Aspirin Use and Prostate Cancer Risk by TMPRSS2:ERG Status. .
27.
2018
Circadian Misalignment and Hepatocellular Carcinoma Incidence in the United States. .
27.
2018
Depression, Antidepressant Use, and Breast Cancer Risk in Pre- and Postmenopausal Women: A Prospective Cohort Study. .
27.
2017
Height, Obesity, and the Risk of TMPRSS2:ERG -Defined Prostate Cancer. .
27.
2017
MYC Overexpression at the Protein and mRNA Level and Cancer Outcomes among Men Treated with Radical Prostatectomy for Prostate Cancer. .
27.
2017
Vasectomy and Risk of Prostate Cancer in a Screening Trial. .
26.
2017
Long-term Particulate Matter Exposures during Adulthood and Risk of Breast Cancer Incidence in the Nurses' Health Study II Prospective Cohort. .
25.
2016
Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions. .
25.
2016
Clinicopathologic Features of Colorectal Carcinoma in HIV-Positive Patients. .
25.
2016
Association of Prostate Cancer Risk Variants with TMPRSS2:ERG Status: Evidence for Distinct Molecular Subtypes. .
25.
2016
Statin Use and Breast Cancer Risk in the Nurses' Health Study. .
25.
2016
Sleep Duration and Disruption and Prostate Cancer Risk: a 23-Year Prospective Study. .
25.
2015
Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid. .
24.
2015
Trajectories of depressive symptoms following breast cancer diagnosis. .
24.
2015
Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk. .
24.
2015
Health care utilization, lifestyle, and emotional factors and mammography practices in the Childhood Cancer Survivor Study. .
24.
2015
Caffeine, coffee, and tea intake and urinary estrogens and estrogen metabolites in premenopausal women. .
24.
2015
Adult body size and physical activity in relation to risk of breast cancer according to tumor androgen receptor status. .
24.
2015
Inherited genetic variants associated with occurrence of multiple primary melanoma. .
24.
2015
Dense and nondense mammographic area and risk of breast cancer by age and tumor characteristics. .
24.
2015
Association of prostate cancer risk variants with gene expression in normal and tumor tissue. .
24.
2014
Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. .
24.
2014
Sun exposure and melanoma survival: a GEM study. .
23.
2014
Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancer. .
23.
2014
Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer. .
23.
2014
Serum immunoglobulin e and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. .
23.
2014
Cancer screening and genetics: a tale of two paradigms. .
23.
2014
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment. .
23.
2014
Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer. .
22.
2013
Plasma C-peptide, mammographic breast density, and risk of invasive breast cancer. .
22.
2013
Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study. .
22.
2013
Prospective analysis of association between statin use and breast cancer risk in the women's health initiative. .
22.
2013
Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to the time since the mammogram. .
22.
2013
Dairy intakes in older girls and risk of benign breast disease in young women. .
22.
2013
Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. .
22.
2013
A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region. .
21.
2012
Insulin therapy and colorectal adenomas in patients with diabetes mellitus. .
21.
2012
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. .
21.
2012
Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk. .
21.
2012
The impact of race and comorbidity on survival in endometrial cancer. .
21.
2012
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. .
21.
2012
Vitamin D and calcium supplementation and one-year change in mammographic density in the women's health initiative calcium and vitamin D trial. .
21.
2012
Tissue and serum mesothelin are potential markers of neoplastic progression in Barrett's associated esophageal adenocarcinoma. .
21.
2012
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). .
21.
2011
Chemotherapy and thyroid cancer risk: a report from the childhood cancer survivor study. .
21.
2011
FIB-4 index is associated with hepatocellular carcinoma risk in HIV-infected patients. .
20.
2011
Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer. .
20.
2011
MET expression and amplification in patients with localized gastric cancer. .
20.
2011
A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening. .
20.
2010
Dating the rise of esophageal adenocarcinoma: analysis of Connecticut Tumor Registry data, 1940-2007. .
20.
2010
Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma. .
19.
2010
Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development. .
19.
2010
Effect of long-term storage in TRIzol on microarray-based gene expression profiling. .
19.
2010
Associations of cumulative sun exposure and phenotypic characteristics with histologic solar elastosis. .
19.
2010
The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes. .
19.
2010
Empirical estimates of the lead time distribution for prostate cancer based on two independent representative cohorts of men not subject to prostate-specific antigen screening. .
19.
2010
Risk of meningioma and common variation in genes related to innate immunity. .
19.
2010
Cardiovascular risk factors in adult survivors of pediatric cancer--a report from the childhood cancer survivor study. .
19.
2010
Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer. .
19.
2010
Smoking cessation and relapse during a lung cancer screening program. .
18.
2009
Common variation in genes related to innate immunity and risk of adult glioma. .
18.
2009
Physical activity among lung cancer survivors: changes across the cancer trajectory and associations with quality of life. .
18.
2009
Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma. .
18.
2009
Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites. .
17.
2008
Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma. .
17.
2008
A population-based, descriptive analysis of malignant intraductal papillary mucinous neoplasms of the pancreas. .
17.
2008
Cigarette smoking and risk of lung metastasis from esophageal cancer. .
17.
2008
Common 8q24 sequence variations are associated with Asian Indian advanced prostate cancer risk. .
17.
2008
Effects of socioeconomic status and treatment disparities in colorectal cancer survival. .
17.
2008
Comparing genetic ancestry and self-described race in african americans born in the United States and in Africa. .
17.
2008
A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study. .
17.
2008
The polyp prevention trial continued follow-up study: no effect of a low-fat, high-fiber, high-fruit, and -vegetable diet on adenoma recurrence eight years after randomization. .
16.
2007
Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. .
16.
2007
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. .
16.
2007
Physical inactivity in adult survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study. .
16.
2007
Cardiovascular risk profile of patients with HER2/neu-positive breast cancer treated with anthracycline-taxane-containing adjuvant chemotherapy and/or trastuzumab. .
16.
2007
Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma. .
16.
2007
Reproductive history and risk of second primary breast cancer: the WECARE study. .
16.
2007
Overweight and obese perimenopausal and postmenopausal women exhibit increased abnormal mammary epithelial cytology. .
16.
2007
Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. .
16.
2007
Lead, genetic susceptibility, and risk of adult brain tumors. .
15.
2006
Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2. .
15.
2006
The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study. .
15.
2006
Tobacco use in adult long-term survivors of retinoblastoma. .
15.
2006
Psychosocial mediators of a nurse intervention to increase skin self-examination in patients at high risk for melanoma. .
15.
2006
RNASEL mutation screening and association study in Ashkenazi and non-Ashkenazi prostate cancer patients. .
15.
2006
Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions. .
15.
2006
Endogenous sex hormone levels and mammographic density among postmenopausal women. .
14.
2005
A comparison of bilateral breast cancers in BRCA carriers. .
14.
2005
Fruit and vegetable intake during pregnancy and risk for development of sporadic retinoblastoma. .
14.
2005
Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men. .
14.
2005
Influence of type of cigarette on peripheral versus central lung cancer. .
14.
2005
Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer. .
14.
2005
A prospective study of perceived susceptibility to breast cancer and nonadherence to mammography screening guidelines in African American and White women ages 40 to 79 years. .
13.
2004
Diet and melanoma in a case-control study. .
13.
2004
Manganese superoxide dismutase polymorphism, plasma antioxidants, cigarette smoking, and risk of breast cancer. .
13.
2004
Decreased retinoid X receptor-alpha protein expression in basal cells occurs in the early stage of human prostate cancer development. .
13.
2004
Cancer in first-degree relatives and risk of glioma in adults. .
12.
2003
The HRAS1 variable number of tandem repeats and risk of breast cancer. .
12.
2003
Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial. .
12.
2003
The relationship between twenty missense ATM variants and breast cancer risk: the Multiethnic Cohort. .
12.
2003
Pregnancy hormones, pre-eclampsia, and implications for breast cancer risk in the offspring. .
12.
2003
Handedness and risk of brain tumors in adults. .
12.
2003
Polio vaccination and risk of brain tumors in adults: no apparent association. .
12.
2003
Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer. .
12.
2003
Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors. .
12.
2003
Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women. .
11.
2002
P gene as an inherited biomarker of human eye color. .
11.
2002
Oral cancer risk perception among participants in an oral cancer screening program. .
11.
2002
Alcoholism and risk for cancer of the cervix uteri, vagina, and vulva. .
10.
2001
Inverse associations between plasma lycopene and other carotenoids and prostate cancer. .
10.
2001
Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma. .
10.
2001
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. .
10.
2001
GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a case-control study in a Chinese population. .
9.
2000
Evaluation of factors associated with skin self-examination. .
8.
1999
Cigarette smoking and chromosome 9 alterations in bladder cancer. .
6.
1997
A note on the estimation of relative risks of rare genetic susceptibility markers. .
6.
1997
5 alpha-reductase activity and prostate cancer: a case-control study using stored sera. .
6.
1997
p53 mutations and occupational exposures in a surgical series of lung cancers. .
5.
1996
Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol, and socioeconomic factors. .
5.
1996
Simian virus 40 and pleural mesothelioma in humans. .
5.
1996
The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics. .
5.
1996
The polyp prevention trial II: dietary intervention program and participant baseline dietary characteristics. .
5.
1996
Recognition and classification of clinically dysplastic nevi from photographs: a study of interobserver variation. .
4.
1995
Statistical analysis of molecular epidemiology studies employing case-series. .
3.
1994
Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancer. .
3.
1994
Prostitution, HIV, and cervical neoplasia: a survey in Spain and Colombia. .
2.
1993
TDLU Involution and Breast Cancer Risk-Reply. .
30.
2021
Reflections on publication criteria for genetic association studies. .
14.
2005
The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium.
2017
Systematic Review of Tobacco Use after Lung or Head/Neck Cancer Diagnosis: Results and Recommendations for Future Research.
2015
Opportunities and challenges for the use of large-scale surveys in public health research: a comparison of the assessment of cancer screening behaviors.
2014
Identity
ISO Abbreviation
Cancer Epidemiol Biomarkers Prev
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)
